十一月 2025
- Home
- GeneSight
十一月 2025的GeneSight市场份额分析
GeneSight Psychotropic is a pharmacogenomic test which means that it analyzes how your genes may affect medication outcomes. The GeneSight test analyzes clinically important genetic variations in your DNA. Results can inform your healthcare provider about how you may break down or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions.
GeneSight(包含公司地区分支机构)
查看更多网站流量和参与度信息- genesight.com
GeneSight热门域名的总访问量
了解GeneSight市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
GeneSight热门域名的平均访问时长
分析GeneSight参与度指标。
过去 3 个月的平均访问时长
子公司明细
GeneSight热门域名的平均页面浏览量
了解GeneSight如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
GeneSight 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Genesight launched commercial PGx testing laboratory focused on psychotropic drugs on Jan 1st '06.In 2006, Myriad Genetics' predecessor company, Assurex Health, using technology licensed from Cincinnati Children's Hospital Medical Center and the Mayo Clinic, launched the first commercial PGx testing laboratory focused on psychotropic drugs.
四月 30, 2025阅读更多
新闻Brookfield partnered with Genesight on Sep 2nd '23.Brookfield, CT- HIAAH, a mental healthcare provider sector leader, recently announced their partnership with GeneSight, a pharmacogenomic test provider, to provide accurate dosage information for certain medications.
九月 30, 2023阅读更多
查看 GeneSight 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。